Your specialist never called back. It is not because they do not want to see you. It is because their office is drowning in faxed referrals, manual data entry, and phone calls that nobody has time to answer. AI startup Basata has raised $21 million in Series A funding to fix that problem — using AI voice agents and document processing to close the gap between a referral being sent and a patient getting scheduled.
The Problem Is Enormous
When a primary care doctor refers you to a cardiologist or urologist, the referral typically arrives at the specialist's office by fax. Administrative staff must read the document, extract relevant clinical information, enter it into the practice's electronic medical records, and then call the patient to schedule. Many practices process hundreds or thousands of referrals with small teams.
The result is predictable. Patients wait weeks or months. Some never hear back at all. Basata co-founder Kaled Alhanafi described his own father's experience. After a serious carotid artery diagnosis, his father was referred to three cardiology groups. One called within two weeks. Another called after the surgery was already done. The third still has not called.
These are not unusual outcomes. The care gap between referral and appointment is one of the biggest unsolved problems in American healthcare. It is not a technology problem in the traditional sense. It is an administrative capacity problem that AI is uniquely suited to solve.
What Basata Does
When a faxed referral arrives, Basata's AI system reads the document, extracts the clinical information, and processes it into the practice's medical records. Then an AI voice agent calls the patient directly to schedule the appointment. Patients can also call the practice at any hour and reach an AI agent that handles prescription renewals, scheduling changes, and common questions.
The goal is for a patient to have a scheduled appointment by the time they reach their car after seeing their primary care doctor. Alhanafi says recordings show patients audibly surprised by how quickly they are contacted.
The company integrates with specialty-specific electronic medical record systems. It started with cardiology. Then expanded to urology. It recently turned down a large deal in a specialty it had not yet mapped thoroughly enough. That discipline — expanding carefully rather than chasing every opportunity — reflects the founders' backgrounds. CEO Alhanafi previously worked at Lyft and Cruise. Co-founder Chetan Patel spent a decade building cardiac devices at Medtronic.
The Numbers
Basata has processed referrals for roughly 500,000 patients to date. About 100,000 of those came in the last month alone — a trajectory that suggests rapid acceleration. The company says 70 percent of new deals now come through word of mouth from existing customers.
The revenue model is usage-based. Practices pay per document processed and per call handled rather than per seat. That structure aligns incentives — Basata earns more when practices process more patients.
The Funding
The $21 million Series A was led by Lan Xuezhao of Basis Set Ventures. Cowboy Ventures, founded by Aileen Lee, also participated. Victoria Treyger, a former Felicis partner who recently launched her own firm Sofeon, made the deal her first investment.
Lee cited the founders' experience as a key differentiator. There are a lot of VCs chasing young dropouts, she said, but when selling to medical practices, trust matters enormously. Doctors want to look you in the eye and know they can count on you.
The Competition Is Heating Up
The healthcare AI back office is attracting serious capital. Tennr, a New York-based startup, has raised over $160 million from a16z, IVP, Lightspeed, and Google Ventures at a $605 million valuation. Tennr focuses on document intelligence with proprietary language models trained on tens of millions of medical records. Assort Health, backed by Lightspeed, automates patient phone communication at a $750 million valuation.
Basata argues its differentiation is combining both capabilities — document processing and voice AI — into a single end-to-end workflow tailored to specific specialties. Whether that approach survives as better-funded competitors expand remains the central competitive question.
The Jobs Question
Like every AI company automating work that humans currently do, Basata faces the question of whether it is augmenting or replacing workers. The founders say the administrative staff they work with are not worried about displacement. They are worried about drowning. Many have been in their roles for decades. They know the work intimately. They are buried in volume that no reasonable number of hires could absorb.
Whether AI merely expands what these workers can do — or gradually makes their functions unnecessary — is a question that extends well beyond healthcare. For now, Basata's pitch is the former. And judging by the word-of-mouth growth, the people closest to the problem find that argument convincing.
